Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period
Launched by CIBA VISION · Dec 17, 2008
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Current soft contact lens wearer who wear their habitual lenses for no less than 10 hours a day, 5 days a week
- • Have a need for correction in both eyes and be correctable to at least 20/40 distance vision in each eye while wearing trial lenses
- • Replace lenses on a weekly or longer schedule
- • Other protocol inclusion/exclusion criteria may apply
- Exclusion Criteria:
- • Requires concurrent ocular medication
- • Eye injury or surgery within twelve weeks immediately prior to enrollment
- • Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of their accessory solutions
- • Current soft toric lens wearers
- • Those who dispose of their soft lenses on a daily basis
- • Current NIGHT \& DAY® or Biofinity® lens wearers
- • Other protocol-defined inclusion/exclusion criteria may apply
About Ciba Vision
Ciba Vision, a global leader in the development and manufacturing of innovative eye care products, specializes in contact lenses and lens care solutions. With a strong commitment to enhancing visual health and improving patient outcomes, Ciba Vision focuses on research and development to deliver cutting-edge technologies and products that meet the evolving needs of eye care professionals and consumers. The company is dedicated to advancing clinical trials that explore new therapies and solutions in ophthalmology, ensuring the highest standards of safety and efficacy in its offerings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials